GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)
Financial Results:
- Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q1FY24 of ₹762.00 Crores up from ₹745.00 Crore year on year, a rise of 2.28%.
- Total Expenses for Q1FY24 of ₹634.00 Crores up from ₹613.00 Crores year on year, a rise of 3.43%.
- Consolidated Net Profit of ₹132.00 Crores up 10.92% from ₹119.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹7.81, up 10.94% from ₹7.04 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.